{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:03:07Z","timestamp":1782907387842,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100016767","name":"United Network for Organ Sharing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.transproceed.2022.12.015","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T15:56:12Z","timestamp":1676649372000},"page":"317-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Kidney Transplantation in an Elderly Veteran Population With Hepatitis C Virus Nucleic Acid Test\u2013Positive Donors Results in Improved Outcomes After Prophylactic Glecaprevir\/Pibrentasvir Therapy"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8467-2300","authenticated-orcid":false,"given":"Reynold I.","family":"Lopez-Soler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Thorndyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Trotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry","family":"Zingraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Sorenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manpreet","family":"Samra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl. 2","key":"10.1016\/j.transproceed.2022.12.015_bib0001","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.16502","article-title":"Optn\/srtr 2019 annual data report: kidney","volume":"21","author":"Hart","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0002","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/ajt.15198","article-title":"Report from the american society of transplantation on frailty in solid organ transplantation","volume":"19","author":"Kobashigawa","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0003","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2215\/CJN.01280209","article-title":"Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased\u2013donor transplant","volume":"4","author":"Schold","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0004","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1111\/ajt.15355","article-title":"Center-level trends in utilization of HCV-exposed donors for HCV-uninfected kidney and liver transplant recipients in the united states","volume":"19","author":"Bowring","year":"2019","journal-title":"Am J Transplant"},{"issue":"suppl. 1","key":"10.1016\/j.transproceed.2022.12.015_bib0005","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/ajt.15679","article-title":"Optn\/srtr 2018 annual data report: hepatitis c","volume":"20","author":"Wang","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0006","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000486516","article-title":"Effect of the opioid crisis on the donor pool for kidney transplantation: an analysis of national kidney deceased donor trends from 2010-2016","volume":"47","author":"Chute","year":"2018","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0007","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1681\/ASN.2019050462","article-title":"National trends in utilization and 1-year outcomes with transplantation of HCV-viremic kidneys","volume":"30","author":"Potluri","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0008","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/ajt.16834","article-title":"Association of donor hepatitis c virus infection status and risk of bk polyomavirus viremia after kidney transplantation","volume":"22","author":"Molnar","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0009","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/ajt.15583","article-title":"Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: a unique complication in the daa era","volume":"20","author":"Kapila","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.31011","article-title":"Hepatitis c virus nat-positive solid organ allografts transplanted into hepatitis c virus\u2013negative recipients: a real-world experience","volume":"72","author":"Kapila","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0011","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/TP.0000000000002949","article-title":"Impact of donor hepatitis c virus on kidney transplant outcomes for hepatitis c-positive recipients in the direct-acting antiviral era: Time to revise the kidney donor risk index?","volume":"104","author":"Cannon","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0012","doi-asserted-by":"crossref","first-page":"663","DOI":"10.12659\/AOT.905428","article-title":"Is kidney donor profile index (KDPI) valid for hepatitis c aviremic kidneys?","volume":"22","author":"Sibulesky","year":"2017","journal-title":"Ann Transplant"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0013","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/tri.13743","article-title":"Donor hepatitis c antibody positivity misclassifies kidney donor profile index in non-hepatitis c-infected donors: time to revise the kidney donor profile index \u2013 a retrospective cohort study","volume":"33","author":"Yazawa","year":"2020","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0014","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/M18-0749","article-title":"Twelve-month outcomes after transplant of hepatitis c-infected kidneys into uninfected recipients: a single-group trial","volume":"169","author":"Reese","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M17-2871","article-title":"Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis c virus-infected donors to noninfected recipients: an open-label nonrandomized trial","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0016","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1111\/ajt.15530","article-title":"Transplantation of kidneys from hepatitis c-infected donors to hepatitis c-negative recipients: single center experience","volume":"19","author":"Molnar","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0017","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1681\/ASN.2020050686","article-title":"Multicenter study to transplant hepatitis c-infected kidneys (mythic): an open-label study of combined glecaprevir and pibrentasvir to treat recipients of transplanted kidneys from deceased donors with hepatitis c virus infection","volume":"31","author":"Sise","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0018","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa1812406","article-title":"Heart and lung transplants from HCV-infected donors to uninfected recipients","volume":"380","author":"Woolley","year":"2019","journal-title":"N Eng J Med"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0019","doi-asserted-by":"crossref","first-page":"e13624","DOI":"10.1111\/ctr.13624","article-title":"Outcomes of dcd kidneys recovered for transplantation with versus without pre-mortem heparin administration","volume":"33","author":"Narvaez","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0020","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3389\/fimmu.2020.00631","article-title":"Transplanting marginal organs in the era of modern machine perfusion and advanced organ monitoring","volume":"11","author":"Resch","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0021","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2215\/CJN.07190715","article-title":"Epidemiology of kidney discard from expanded criteria donors undergoing donation after circulatory death","volume":"11","author":"Singh","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0022","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.transproceed.2017.11.034","article-title":"Outcomes of controlled donation after cardiac death compared with donation after brain death in liver transplantation: a systematic review and meta-analysis","volume":"50","author":"Tang","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0023","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/1526924819874373","article-title":"Hepatitis c virus positivity should not be included in the kidney donor profile index calculation when transplanting HCV-positive kidneys into noninfected recipients in the era of direct-acting antiviral agents","volume":"29","author":"Graham","year":"2019","journal-title":"Prog Transplant"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0024","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1097\/TP.0000000000002323","article-title":"Changes in utilization and discard of HCV antibody-positive deceased donor kidneys in the era of direct-acting antiviral therapy","volume":"102","author":"Bowring","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.12.015_bib0025","first-page":"438","article-title":"Real-world direct-acting antiviral treatment in kidney transplant and hemodialysis patients: the epiter-2 multicenter observational study","volume":"34","author":"Tronina","year":"2021","journal-title":"Ann Gastroenterol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134523000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134523000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:44:45Z","timestamp":1758577485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134523000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0041134523000064"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.12.015","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney Transplantation in an Elderly Veteran Population With Hepatitis C Virus Nucleic Acid Test\u2013Positive Donors Results in Improved Outcomes After Prophylactic Glecaprevir\/Pibrentasvir Therapy","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}